WO2002081517A3 - Nouveaux polypeptides et acides nucleiques codant pour ces derniers - Google Patents

Nouveaux polypeptides et acides nucleiques codant pour ces derniers Download PDF

Info

Publication number
WO2002081517A3
WO2002081517A3 PCT/US2002/002064 US0202064W WO02081517A3 WO 2002081517 A3 WO2002081517 A3 WO 2002081517A3 US 0202064 W US0202064 W US 0202064W WO 02081517 A3 WO02081517 A3 WO 02081517A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
novel polypeptides
acids encoded
polypeptides
disclosed
Prior art date
Application number
PCT/US2002/002064
Other languages
English (en)
Other versions
WO2002081517A2 (fr
Inventor
Marc F Decristofaro
Muralidhara Padigaru
Charles Miller
Velizar Tchernev
Haihong Zhong
Mei Zhong
David Anderson
Robert Ballinger
Valerie Gerlach
Kimberly A Spytek
Original Assignee
Curagen Corp
Marc F Decristofaro
Muralidhara Padigaru
Charles Miller
Velizar Tchernev
Haihong Zhong
Mei Zhong
David Anderson
Robert Ballinger
Valerie Gerlach
Kimberly A Spytek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Marc F Decristofaro, Muralidhara Padigaru, Charles Miller, Velizar Tchernev, Haihong Zhong, Mei Zhong, David Anderson, Robert Ballinger, Valerie Gerlach, Kimberly A Spytek filed Critical Curagen Corp
Priority to CA002435528A priority Critical patent/CA2435528A1/fr
Priority to EP02736481A priority patent/EP1360198A2/fr
Priority claimed from US10/055,877 external-priority patent/US7112668B2/en
Publication of WO2002081517A2 publication Critical patent/WO2002081517A2/fr
Priority claimed from US10/453,372 external-priority patent/US20060003323A1/en
Publication of WO2002081517A3 publication Critical patent/WO2002081517A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouveaux polypeptides et des acides nucléiques codant pour ces derniers. Cette invention concerne aussi des vecteurs, des cellules hôtes, des anticorps et des techniques de recombinaison permettant de produire ces polypeptides et ces polynucléotides, ainsi que des techniques d'utilisation de ceux-ci.
PCT/US2002/002064 2001-01-19 2002-01-22 Nouveaux polypeptides et acides nucleiques codant pour ces derniers WO2002081517A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002435528A CA2435528A1 (fr) 2001-01-19 2002-01-22 Nouveaux polypeptides et acides nucleiques codant pour ces derniers
EP02736481A EP1360198A2 (fr) 2001-01-19 2002-01-22 Polypeptides et acides nucleicsles encodant

Applications Claiming Priority (57)

Application Number Priority Date Filing Date Title
US26289201P 2001-01-19 2001-01-19
US60/262,892 2001-01-19
US26359801P 2001-01-23 2001-01-23
US60/263,598 2001-01-23
US26379901P 2001-01-24 2001-01-24
US60/263,799 2001-01-24
US26411701P 2001-01-25 2001-01-25
US26413901P 2001-01-25 2001-01-25
US60/264,139 2001-01-25
US60/264,117 2001-01-25
US26447801P 2001-01-26 2001-01-26
US60/264,478 2001-01-26
US26335101P 2001-01-30 2001-01-30
US60/263,351 2001-01-30
US27287001P 2001-03-02 2001-03-02
US60/272,870 2001-03-02
US27592701P 2001-03-14 2001-03-14
US27599001P 2001-03-14 2001-03-14
US60/275,927 2001-03-14
US60/275,990 2001-03-14
US27644901P 2001-03-15 2001-03-15
US60/276,449 2001-03-15
US27735801P 2001-03-20 2001-03-20
US60/277,358 2001-03-20
US27515101P 2001-03-23 2001-03-23
US27815101P 2001-03-23 2001-03-23
US60/278,151 2001-03-23
US27985701P 2001-03-29 2001-03-29
US60/279,857 2001-03-29
US28514001P 2001-04-20 2001-04-20
US28514101P 2001-04-20 2001-04-20
US60/285,140 2001-04-20
US60/285,141 2001-04-20
US28748401P 2001-04-30 2001-04-30
US60/287,484 2001-04-30
US29170101P 2001-05-17 2001-05-17
US60/291,701 2001-05-17
US29696001P 2001-06-08 2001-06-08
US60/296,960 2001-06-08
US30435301P 2001-07-10 2001-07-10
US30435501P 2001-07-10 2001-07-10
US60/304,355 2001-07-10
US60/304,353 2001-07-10
US30488601P 2001-07-12 2001-07-12
US60/304,886 2001-07-12
US31128901P 2001-08-09 2001-08-09
US60/311,289 2001-08-09
US31197501P 2001-08-13 2001-08-13
US60/311,975 2001-08-13
US31293701P 2001-08-16 2001-08-16
US60/312,937 2001-08-16
US33022701P 2001-10-18 2001-10-18
US60/330,227 2001-10-18
US33419801P 2001-11-29 2001-11-29
US60/334,198 2001-11-29
US10/055,877 US7112668B2 (en) 2001-01-23 2002-01-22 Polypeptides and nucleic acids encoded thereby
US10/453,372 US20060003323A1 (en) 2000-03-01 2003-06-03 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Publications (2)

Publication Number Publication Date
WO2002081517A2 WO2002081517A2 (fr) 2002-10-17
WO2002081517A3 true WO2002081517A3 (fr) 2003-08-28

Family

ID=38137551

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/002064 WO2002081517A2 (fr) 2001-01-19 2002-01-22 Nouveaux polypeptides et acides nucleiques codant pour ces derniers

Country Status (1)

Country Link
WO (1) WO2002081517A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004515207A (ja) * 2000-02-03 2004-05-27 ハイセック，インコーポレーテッド メタロカルボキシペプチダーゼ様ポリペプチドおよびポリヌクレオチドに関する方法と材料
WO2003002722A2 (fr) * 2001-06-29 2003-01-09 The Board Of Trustees Of The Leland Stanford Junior University Genes regulateurs de lymphocytes t et leurs methodes d'utilisation
US8709412B2 (en) 2001-06-29 2014-04-29 The Board Of Trustees Of The Leland Stanford Junior University Modulation of TIM receptor activity in combination with cytoreductive therapy
AU2003228336B2 (en) * 2002-03-19 2009-07-30 Curagen Corporation Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003090771A2 (fr) * 2002-04-25 2003-11-06 Bayer Healthcare Ag Diagnostique et therapeutique de maladies associees aux recepteurs 3 d'amine sous forme de traces (ta3)
US7297525B2 (en) * 2002-11-27 2007-11-20 Wyeth Composition employing a novel human kinase
EP1685159B1 (fr) 2003-10-03 2012-08-01 Brigham & Women's Hospital Polypeptides de Tim-3
WO2005040803A1 (fr) * 2003-10-21 2005-05-06 Bayer Healthcare Ag Diagnostics et therapeutique destines a des maladies associees a l'element 6 de type 2 de famille 22 de support de solute humain (slc22a6-type2)
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
TW200539890A (en) 2004-03-12 2005-12-16 Brigham & Womens Hospital Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
CA2971303A1 (fr) 2016-06-21 2017-12-21 Bamboo Therapeutics, Inc. Genes de mini-dystrophine optimises et cassettes d'expression et leur utilisation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005254A1 (fr) * 1990-09-25 1992-04-02 Genentech, Inc. Nouveau facteur neurotrophique
WO2002055704A2 (fr) * 2001-01-09 2002-07-18 Curagen Corp Proteines, polynucleotides codant pour elles et procedes d'utilisation correspondants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005254A1 (fr) * 1990-09-25 1992-04-02 Genentech, Inc. Nouveau facteur neurotrophique
WO2002055704A2 (fr) * 2001-01-09 2002-07-18 Curagen Corp Proteines, polynucleotides codant pour elles et procedes d'utilisation correspondants

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BERKEMEIER L R ET AL: "HUMAN CHROMOSOME 19 CONTAINS THE NEUROTROPHIN-5 GENE LOCUS AND THREE RELATED GENES THAT MAY ENCODE NOVEL ACIDIC NEUROTROPHINS", SOMATIC CELL AND MOLECULAR GENETICS, vol. 18, no. 3, 1992, pages 233 - 245, XP002232242, ISSN: 0740-7750 *
IP N Y ET AL: "MAMMALIAN NEUROTROPHIN-4: STRUCTURE, CHROMOSOMAL LOCALIZATION, TISSUE DISTRIBUTION, AND RECEPTOR SPECIFICITY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 89, no. 7, 1 April 1992 (1992-04-01), pages 3060 - 3064, XP000264180, ISSN: 0027-8424 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124617B2 (en) 2005-09-01 2012-02-28 Takeda San Diego, Inc. Imidazopyridine compounds
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
US8008332B2 (en) 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
US8394843B2 (en) 2006-05-31 2013-03-12 Takeda California, Inc. Substituted isoindoles as glucokinase activators
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators

Also Published As

Publication number Publication date
WO2002081517A2 (fr) 2002-10-17

Similar Documents

Publication Publication Date Title
WO2002062999A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2003052055A3 (fr) Endoglucanase egvii et acides nucleiques la codant
WO2003052056A3 (fr) Endoglucanase egviii et acides nucleiques la codant
WO2003052054A3 (fr) Bgl5 béta-glucosidase et acides nucléiques codant ce dernier
WO2003027306A3 (fr) Beta-glucosidase bgl3 et acides nucleiques la codant
WO2004101760A3 (fr) Une nouvelle enzyme lipolytique dite elip
WO2003054152A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003025148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002070539A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003023013A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002081731A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003052057A3 (fr) Endoglucanase egvi et acides nucleiques la codant
WO2003052118A3 (fr) Beta-glucosidase bgl4 et acides nucleiques la codant
WO2001075067A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2002022660A3 (fr) Noveaux acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002031111A3 (fr) Acides nucleiques et polypeptides
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
WO2001088088A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004101759A3 (fr) Nouvelle enzyme lipolytique lip2
WO2002059260A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2435528

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002736481

Country of ref document: EP

Ref document number: 2002309483

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2002736481

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: JP